6533b837fe1ef96bd12a1de7

RESEARCH PRODUCT

A conceptually new treatment approach for relapsed glioblastoma: Coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care

Richard E. KastWeiguang WangKalkunte S. SrivenugopalJohn A. BoockvarWen-wei ChangAlireza KhoshnevisanMarco TuccoriKirsi KetolaMarc Eric HalatschBoris CvekNicolas MagnéSeyed H. GhaffariAvishay SellaGeorg Karpel-masslerDaniele FocosiChristian Rainer WirtzMohammad H. PourgholamiAmeya ParanjpeChristine MarosiKerrie L. McdonaldAnsgar BrüningMiguel MuñozDaniel KeizmanFrancesco CappelloThomas EfferthIacopo SardiQ. Ping DouAlfonso Dueñas-gonzález

subject

medicine.medical_specialtyCaptoprilTel avivMorpholinesArtesunateReviewGluconatesAngiotensinQuality of lifeAuranofinSertralineAntineoplastic Combined Chemotherapy ProtocolsDisulfiramTemozolomidemedicineRecurrent diseaseHumansIn patientNelfinavirTemozolomideBrain Neoplasmsbusiness.industrySuccinatesNeurokininCytotoxic chemotherapyUniversity hospitalmedicine.diseaseArtemisininsSurgeryDacarbazineKetoconazoleOncologyangiotensin aprepitant artesunate auranofin captopril cytokines disulfiram glioblastoma ketoconazole nelfinavir neurokinin sertraline temozolomideFamily medicineCytokinesNeoplasm Recurrence LocalGlioblastomabusinessAprepitantGlioblastomamedicine.drug

description

Kast, Richard E. et al.

https://doi.org/10.18632/oncotarget.969